| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 22324-83-0 | 更他氯铵中间体; 1,2,3,4-四氢-6,7-二甲氧基-2-甲基-1-(3,4,5-三甲氧基苯基)异喹啉 | (+/-)-Cryptostyline III; 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)isoquinoline; intermediate of Gantacurium Chloride |  | C21H27NO5 | 详情 | 供应商 |
| 30131-16-9 | 对苯丁氧基苯甲酸 | 4-(4-Phenylbutoxy)benzoic acid; 4-(4-phenylbutoxy)benzoic acid (intermediate of pranlukast); p-phenylbutoxybenzoic acid |  | C17H18O3 | 详情 | 供应商 |
| 59564-78-2 | 1,3-二苄基咪唑-2-酮-4,5-二羧酸; 环酸 | 1,3-Bisbenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid; 1,3-DIBENZYL IMIDAZOLIDINONE-4,5-DICARBOXYLIC ACID; 1,3-BISBENZYL-2-OXOIMIDAZOLIDINE-4,5-DICARBOXYLIC ACID; 1,3-Dibenzyl-2-Imidaxzolidone-Cis-4,5-Dicarboxylic Acid; Vitamin H intermediates Cyclic acid; 1,3-BISBENZYL-2-OXOIMIDAZOLIDINE-4,5-DI&; CYCLIC ACID; 1,3-Dibenzyl-2-imidax zolidone-cis-4,5-dicarboxylic |  | C19H18N2O5 | 详情 | 供应商 |
| 99464-83-2 | 1-氯乙基环己基碳酸酯 | 1-Chloroethyl cyclohexyl carbonate; 1-Chloroethyl Cyclohexyl Carbonate (intermediate of Candesartan Cilexetil); 1-Chloro Ethyl Cyclohexyl Carbonate; 1-ChloroethylCyclohexylCarbonate; Cyclohexyl-(1-chloroethyl)-carbonate; 1-Chloroethyl Cyclohexyl Carbonate (JCC-2); intermediate of Candesartan Cilexetil; |  | C9H15ClO3 | 详情 | 供应商 |
| 113028-17-4 | 6-氟-7-哌嗪-1-甲基-4-氧代-[1,3]硫氮杂环[3,2-a]喹啉-3-羧酸乙酯 | Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate; ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate; 6-FLUORO-1-METHYL-4-OXO-7(1-PIPERAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER; PRULIFLOXACIN intermediate 2; ETHYL 6-FLUORO-1-METHYL-4-OXO-7-(1-PIPRAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-; Ethyl 6-Fluoro-1-Methyl-4-Oxo-7-91-Piperazinyl)-4h-(1,3-)-Thiazeto-(3,2-A)Quinoline-3-Carboxylate; 6-FLUORO-1-METHYL-4-OXO-7-(1-PIPERAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER; 6-FLUORO-1-METHYL-4-OXO-7-(1-PIPRAZINYL)-1H,4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOXYLIC ACID, ETHYL ESTER; 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1H,4H-[1,3]-thiazeto[3,2-a]-3-quinolinecarboxylic acid ethyl ester |  | C18H20FN3O3S | 详情 | 供应商 |
| 113046-72-3 | 6,7-二氟-1-甲基-4-氧代-4H-[1,3]噻嗪[3,2-a]并喹啉-3-羧酸乙酯 | Ethyl 6,7-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate; PRULIFLOXACIN intermediate 1; 6,7-DIFLUORO-1-METHYL-4-OXO-4H-[1,3]THIAZETO[3,2-A]-3-QUINOLINE CARBOXYLIC ACID ETHYL ESTER; 6,7-DIFLUORO-1-METHYL-4-OXO-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER; 6,7-DIFLUORO-1-METHYL-4-OXO-4H-2-THIA-8B-AZA-CYCLOBUTA[A]NAPHTHALENE-3-CARBOXYLIC ACID ETHYL ESTER; ETHYL 6,7-DIFLUORO-1-METHYL-4-OXO-4H-[1,3]THIAZETO[3,2-A]QUINOLINE-3-CARBOXYLATE; Ethyl 6,7-Difluoro-1-Methyl-4-Oxo-1H,4H-(1,3)Thiazeto(3,2-a)Quinoline-3-Carboxylate; ETHYL 6,7-DIFLUORO-1-METHYL-4-OXO-4H-(1,3-)THIAZETO(3,2,-A)QUINOLINE-3-CARBOXYLA; PRULIFLOXACIN intermediate |  | C14H11F2NO3S | 详情 | 供应商 |
| 114915-14-9 | 多西紫杉醇中间体; 多西他赛中间体 | Docetaxel intermediate; (aR,bS)-beta-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-hydroxy-benzenepropanoic acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester |  | C49H55Cl6NO18 | 详情 | 供应商 |
| 116714-47-7 | 3-氯-4-[1,1,2-三氟-2-(三氟甲氧基)乙氧基]苯胺 | 3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine; NOVALURON intermediate; 3-CHLORO-4-[1,1,2-TRIFLUORO-2-(TRIFLUOROMETHOXY)ETHOXY]BENZENAMINE; 4-trifluoromethoxy trifluoroethoxy-5-chloroaniline |  | C9H6ClF6NO2 | 详情 | 供应商 |
| 118288-25-8 | 4-[4-(N-哌啶甲基)吡啶-2-氧]顺-2-丁烯-1-胺 | 4-[4-(Piperidinomethyl)pyridyl-2-oxy]-cis-2-butenamine; 4-(4-PIPERIDIN-1-YL-METHYL-PYRIDIN-2-YL-OXY)-BUT-2-ENYLAMINE; 4-[4-(PIPERIDINOMETHYL)PYRIDYL-2-OXY]-CIS-2-BUTENAMINE; 4-[4-(PIPERIDINOMETHYL)PYRIDYL-2-OXY]-CIS-2-BUTENAMINE(intermediate FOR LAFUTIDINE); 4-[4-(Piperidinomethyl)pyridyl; 4-[4-(PIPERIDINOMETHYL)PYRIDYL-2-OXY]-CIS-2-BUTENAMINE(PREPARATION FOR LAFUTIDINE); 4(E)-4-(4-(PIPERIDIN-1-YLMETHYL)PYRIDIN-2-YLOXY)BUT-2-EN-1-AMINE (intermediate FOR LAFUTIDINE) |  | C15H23N3O | 详情 | 供应商 |
| 134790-39-9 | 2',2'-二氟-2'-脱氧胞嘧啶核苷-3',5'-二苯甲酸酯 | 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate; 2,2-Difluoro-2-deoxycytidine-3,5-dibenzoate; 2?Deoxy-2?2?difluro-3??bis-O-benzoylcytidine; 2-deoxy-2’,2’-difluoro-3’5’-bis-o-benzoyleytidine monohydrochloride; 2,2-Difluoro-2-deoxycyodine-3,5-dibenzoate(or its salt); 2’,2’-Difluoro-2’-deoxycyodine-3’,5’-dibenzoate; 2',2'-difluoro-2'-deoxycyldine-3',5'-dibenzoate; 2',2'-Difluoro-3',5'-dibenzoyl-2'-deoxycytidine; 3',5'-Di-O-benzoyl-2',2'-difluoro-2'-deoxy cytidine; 2'2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate; 2',2'-Difluoro-3',5'--dibenzoyl-2'-deoxycytidine; Gemcitabine HCl intermediate T9; |  | C23H19F2N3O6 | 详情 | 供应商 |
| 146447-26-9 | N-[顺-4-[4-(N-哌啶甲基)吡啶-2-氧]-2-丁烯-1-基]邻苯二甲酰亚胺顺丁烯二酸盐 | N-{4-[4-(Piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleic acid; n-[4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene]phthalimide maleic acid; n-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleate; n-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleic acid(intermediate for lafutidine); n-phthalimide maleic acid; n-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene} |  | C27H29N3O7 | 详情 | 供应商 |
| 160145-82-4 | 泰利霉素中间体5A | 3-De[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-6-O-met; 3-de[(2,6-dideoxy-3-c-methyl-3-o-methyl-a-l-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-6-o-methyl-3-oxo-erythromycin 2’-acetate; Telithromycin intermediate (6A); 2 ∧ -OBEZOYL -3-O-DE [(2, 6-DIDEOXY-3-C-METHYL-3-O-METHYL-α-L-RIBOHEXOPYRANOSYL)OXY]-11-DEOXY-10,11-DIDEHYDRO-6-O-METHYL-3-OXO ERYTHROMYCIN; 2’-OBEZOYL-3-O-DE[(2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-ALPHA-L-RIBOHEXOPYRANOSYL)OXY]-11-DEOXY-10,11-DIDEHYDRO-6-O-METHYL-3-OXO-ERYTHROMYCIN; 3-DE[(2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-A-L-RIBO-HEXOPYRANOSYL)OXY]-10,11-DIDEHYDRO-11-DEOXY-6-O-METHYL-3-OXO-ERYTHROMYCIN 2’-ACETATE; 2 ’’-OBEZOYL -3-O-DE [(2, 6-DIDEOXY-3-C-METHYL-3-O-METHYL-A-L-RIBOHEXOPYRANOSYL)OXY]-11-DEOXY-10,11-DIDEHYDRO-6-O-METHYL-3-OXO ERYTHROMYCIN |  | C32H53NO10 | 详情 | 供应商 |
| 160145-83-5 | 泰利霉素中间体(7A) | Telithromycin intermediate (7A); 2'-Obezoyl-3-O-de[(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribohexopyranosyl)oxy]-11-deoxy-10,11-didehydro-12-O-[(1H-imidazol-1-yl)carbonyl]-6-O-methyl-3-oxo-erythromycin |  | C41H57N3O11 | 详情 | 供应商 |
| 641571-10-0 | 尼罗替尼; 4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺 | Nilotinib; Nilotinib & its intermediates |  | C28H22F3N7O | 详情 | 供应商 |
| 12068-15-4 | Benzenesulfonic acid,dodecyl-, strontium salt (8CI,9CI); Retzloffintermediate No. 3; Strontium dodecylbenzene sulfonate |  | C36H58O6S2Sr | 详情 | 供应商 | |
| 103538-00-7 | Corticotropin-likeintermediate lobe peptide B (Xenopus laevis) (9CI); a18-39-Corticotropin (pig),20-L-isoleucine-27-L-valine-29-L-glutamicacid-31-L-serine-34-L-serine-37-L-methionine-39-L-leucine-; L-Leucine,L-arginyl-L-prolyl-L-leucyl-L-lysyl-L-valyl-L-tyrosyl-L-prolyl-L-asparaginylglycyl-L-valyl-L-a-glutamyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-alanyl-L-a-glutamyl-L-seryl-L-phenylalanyl-L-prolyl-L-methionyl-L-a-glutamyl- |  | C112H173N27O37S | 详情 | 供应商 | |
| 99223-37-7 | Corticotropin-likeintermediate lobe peptide A (Xenopus laevis) (9CI); a18-39-Corticotropin (pig),20-L-isoleucine-27-L-valine-29-L-glutamicacid-31-L-serine-34-L-serine-35-L-tyrosine-37-L-methionine-39-L-leucine-; L-Leucine,L-arginyl-L-prolyl-L-isoleucyl-L-lysyl-L-valyl-L-tyrosyl-L-prolyl-L-asparaginylglycyl-L-valyl-L-a-glutamyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-alanyl-L-a-glutamyl-L-seryl-L-tyrosyl-L-prolyl-L-methionyl-L-a-glutamyl- |  | C112H173N27O38S | 详情 | 供应商 | |
| 53917-42-3 | Corticotropin-likeintermediate lobe peptide (human) (9CI); a18-39-Corticotropin (pig),31-L-serine-; 10: PN: US20090175821 SEQID: 10 claimed protein; 10: PN:WO0069900 SEQID: 10 unclaimed sequence; 1: PN: WO2009040073 PAGE: 98 claimedprotein; 3: PN: EP1990827 SEQID: 3 unclaimed sequence; 40: PN: WO2006017688SEQID: 40 unclaimed sequence; 5: PN: US20050148098 SEQID: 5 unclaimed sequence; CLIP (human); Corticotropin-like intermediate lobe peptide (Macaca nemestrina); Corticotropin-like intermediate lobe peptide (Mustela vison); HumanACTH(18-39); L-Phenylalanine, L-arginyl-L-prolyl-L-valyl-L-lysyl-L-valyl-L-tyrosyl-L-prolyl-L-asparaginylglycyl-L-alanyl-L-a-glutamyl-L-a-aspartyl-L-a-glutamyl-L-seryl-L-alanyl-L-a-glutamyl-L-alanyl-L-phenylalanyl-L-prolyl-L-leucyl-L-a-glutamyl- |  | C112H165N27O36 | 详情 | 供应商 | |
| 32516-05-5 | 1,3,5,7-Tetraazabicyclo[3.3.1]nonane,3,7-diacetyl-; 3,7-Diacetyl-1,3,5,7-tetraazabicyclo[3.3.1]nonane; DAPT; DAPT (explosive intermediate); NSC 281710 |  | C9H16N4O2 | 详情 | 供应商 | |
| 74936-72-4 | 2,6-二甲基-5-甲氧基羰基-4-(3-硝基苯)-1,4-二氢吡啶-3-甲酸 | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl ester; 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, monomethyl ester (9CI); (?à)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylicacid monomethyl ester; (?à)-1,4-Dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylicacid; 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acidmonomethyl ester; 2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylicacid; 5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid (Barnidipine Hcl intermediate); |  | C16H16N2O6 | 详情 | 供应商 |
